Asbestosis
Disease description
A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.
Source: MeSHReferences 4
Download references
Title
with link to reference page |
Journal | Year | Authors |
---|---|---|---|
Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. | Thorax | 2007 |
H. Lehtonen, P. Oksa, L. Lehtimäki, A. Sepponen, R. Nieminen, H. Kankaanranta, S. Saarelainen, R. Järvenpää, J. Uitti, E. Moilanen
Thorax 2007 Jul;62(7):602-7. PubMed:17251310 |
Determination of 8-iso-prostaglandin F(2alpha) in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS. | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | 2008 |
K. Syslová, P. Kacer, M. Kuzma, P. Klusácková, Z. Fenclová, J. Lebedová, D. Pelclová
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008 May;867(1):8-14. PubMed:18373964 |
Reproducibility of exhaled breath condensate markers. | Eur. Respir. J. | 2008 |
S. Chow, DH. Yates, PS. Thomas
Eur. Respir. J. 2008 Oct;32(4):1124-6. PubMed:18827164 |
LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. | J Breath Res | 2010 |
K. Syslová, P. Kačer, M. Kuzma, A. Pankrácová, Z. Fenclová, S. Vlčková, J. Lebedová, D. Pelclová
J Breath Res 2010 Mar;4(1):017104. PubMed:21386209 |
Compounds 4
Download compoundsDL-o-Tyrosine | PubChem CID: 91482 |
Nitric oxide | PubChem CID: 145068 |
8-epi-PGF2alpha | PubChem CID: 5282263 |
8-hydroxy-2-deoxy Guanosine | PubChem CID: 53394351 |
MeSH information
MeSH ID | D001195 |
MeSH name | Asbestosis |